Health Care/Hospital

Fapon showcases its total IVD solutions at Hospital Expo to empower local Indonesian IVD industry

DONGGUAN, China, Oct. 15, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is excited to participate in the Hospital Expo inJakarta, Indonesia, from October 16 – 19. Fapon will showcase its total IVD solutions, including IVD raw materials, reagent services and open-system instr...

2024-10-15 16:28 1399

Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program

83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 LONDON, Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the success of its annualCitation Laureates™ p...

2024-10-15 15:00 1167

DBN Group Invites Global Agricultural Biotech Companies to Co-create a Leading Innovation Ecosystem at DBN Phoenix International Innovation Park

BEIJING, Oct. 15, 2024 /PRNewswire/ -- DBN Group , a leading high-tech agricultural enterprise, has opened its Phoenix International Innovation Park for global applications from high-quality agricultural biotech companies. This initiative seeks to establish an ope...

2024-10-15 13:45 1820

Aidoc and Integral Diagnostics (IDX) Expand AI Partnership in Australia and New Zealand

Aidoc's AI technology enhances radiology services at IDX, significantly improving patient care and service and well-placed to support the upcoming National Lung Cancer Screening Program. MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Aidoc, a global pioneer in clinical AI solutions, today a...

2024-10-15 11:28 1244

PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration

* Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascending dose 4 mg cohort. * PMC-403 is being explored in broader therapeutic areas, including rare vascular disease systemic capillary leak syndrome (SCLS) and kidney...

2024-10-15 09:51 1293

CooperVision to Host 4th Asia-Pacific Myopia Management Symposium in Seoul, South Korea

Held in partnership with the Korean Association of Paediatric Ophthalmology and Strabismus (KAPOS), the event will focus on advancing paediatric myopia management and shaping the future of eye health across the region. SINGAPORE, Oct. 15, 2024 /PRNewswire/ -- CooperVision

2024-10-15 09:00 3588

The Clinician Partners with Queensland Health for Statewide Implementation of Patient Reported Measures and Patient Safety Culture Surveys

BRISBANE, Australia, Oct. 15, 2024 /PRNewswire/ -- The Clinician has been awarded a statewide contract by Queensland Health to implement their ZEDOC platform. This platform will enhance the collection and analysis of Patient Reported Measures (PRMs) and patient safety culture (PSC) staff surveys ...

2024-10-15 06:47 1239

Illuma, Global Pioneer in HMO Research, Launches Traceability Journey in Switzerland, Unveiling Next-Generation HMO Innovations

VEVEY, Switzerland, Oct. 14, 2024 /PRNewswire/ -- Recently at Nestlé's headquarters inVevey, Switzerland, illuma, a global super premium brand of maternal and infant nutrition under Nestlé, began its "Human Milk Oligosaccharides (HMO) Research Traceability Journey". With a focus on the most rece...

2024-10-14 23:31 1207

Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer

Highlights * United States Food and Drug Administration (U.S. FDA) provided positive feedback on a pivotal Phase III trial for64Cu-SAR-bisPSMA diagnostic in prostate cancer patients with biochemical recurrence (BCR), AMPLIFY. * The positive results of the completed COBRA and PROPELLER trials,...

2024-10-14 21:02 1821

Everise Honored as Leading Disability Employer 2024 by National Organization on Disability

PLANTATION, Fla., Oct. 14, 2024 /PRNewswire/ -- Global healthcare customer experience company Everise today announced that it has been recognized by the National Organization on Disability (NOD) as a Leading Disability Employer for 2024. This prestigious honor highlights the company's ongoing com...

2024-10-14 21:00 3778

Metabolon Launches New "Guide to Multiomics" and Accompanying Multiomics Webinar

Metabolon's new multiomics guide and webinar demystify complex omics technologies and illuminate how integrated multiomics is transforming life science research MORRISVILLE, N.C., Oct. 14, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wid...

2024-10-14 21:00 1196

Vivance Completes Pre-Pivotal Trial of Wearable Dialysis Device; Results to be Shared at ASN Kidney Week 2024

SINGAPORE, Oct. 14, 2024 /PRNewswire/ -- Vivance, a leader in kidney care innovations, is proud to announce that the next trial phase of the wearable peritoneal dialysis (PD) device, Viva Kompact, has successfully concluded. The study was conducted at Singapore General Hospital (SGH),Singapore. T...

2024-10-14 21:00 1917

Tsingke Shines at Cell & Gene Therapy International 2024

BEIJING and BOSTON, Oct. 14, 2024 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd. recently concluded a successful exhibition at CGTI2024 inBoston. This premier event attracted over 3,200 global attendees, including professionals from the top 20 biopharma companies. Tsingke showcased its innovat...

2024-10-14 20:11 1478

US FDA issues Study May Proceed letter for the Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors, Sponsored by the US National Cancer Institute

TAIPEI and SAN DIEGO, Oct. 14, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that FDA issues Study May Proceed letter for its developing drug Pid...

2024-10-14 19:00 1783

Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development

* S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation * The platform can address challenges associated with viscosity and achieve stable liquid formulation for over 200 mg/mL subcutaneous administration INCHEON, South Korea, Oct. 14, 2024 /PRNe...

2024-10-14 19:00 1663

Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting

NEW YORK, Oct. 14, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading developer and provider of microwave ablation ("MWA") medical devices inChina, which recently expanded into the U.S. market following its U.S. FDA 510(k) clea...

2024-10-14 17:00 1011

BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 with simultaneous publication of the trial data in the Journal of the American Society of Nephrology (JASN)

SHANGHAI, Oct. 14, 2024 /PRNewswire/ -- BioCity Biopharma announced that a late-breaking clinical trial abstract of its endothelin receptor type A (ETA) selective antagonist SC0062 has been selected for oral presentation at ASN Kidney Week 2024 which will take place fromOctober 23 to 27 in San Di...

2024-10-14 15:38 1597

Embark on a Journey of Holistic Wellbeing at Banyan Tree Dubai's Brand-New Spa

Offering seven private ensuite treatment rooms featuring jacuzzis and showers, the spa provides the ideal retreat to unwind, complemented by vitality pools, heated loungers, and the signature Rainforest experience DUBAI, UAE, Oct. 14, 2024 /PRNewswire/ -- Relaxation takes on a renewed essence at...

2024-10-14 13:00 2434

Novotech Awarded Frost & Sullivan's 2024 Global Company of the Year Award for Its Leadership and Excellence in Biotech CRO Services

Novotech's innovative full-service approach accelerates clinical development with advanced analytics, diverse global patient access, and specialized technology. SAN ANTONIO, Oct. 14, 2024 /PRNewswire/ -- Frost & Sullivan recently conducted an in-depth analysis of the biotech contract research or...

2024-10-14 12:30 1199

21st TAITA Annual Conference Explores Taiwan's AI Era Strategies in the Global Tech Supply Chain

TAIPEI, Oct. 13, 2024 /PRNewswire/ -- The upcoming 21st TAITA-SV Annual Conference, scheduled forSaturday, October 19, 2024, at the Hyatt Regency Hotel inSanta Clara, California, will focus on the theme "Taiwan's Strategic Layout in the AI Era." The conference will explore howTaiwan leverages its...

2024-10-14 10:32 1260
1 ... 44454647484950 ... 858